Sunscreen Trade Groups Urge 'Modern' Risk Assessments For Ingredients

FDA should revise its draft guidance on OTC sunscreen GRASE data to reflect modern toxicological risk assessment, CHPA and PCP say.

More from Approval Standards

More from Pathways & Standards